Clinical Trial: A Study of Eltrekibart (LY3041658) in Healthy Participants

U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07545590) titled 'A Study of Eltrekibart (LY3041658) in Healthy Participants' on April 16.

Brief Summary: The main purpose of this study is to evaluate how eltrekibart is absorbed by the body when it is given under the skin to healthy participants.

The study will last about 17 weeks.

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: LY3041658

Administered SC

DRUG: LY3041658

Administered IV

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eli Lilly and Company

Disclaimer: Curated by HT Syndication....